123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: Paradoxical positivity in an oncocytic adrenocortical carcinoma;123I-Methyljodbenzylguanidin- (MIBG-) szintigraphie: Paradoxe nuklidspeicherung eines onkozytären nebennierenrindenkarzinoms

Pathologe

Volumn 28, Issue 4, 2007, Pages 281-284

  Padberg, B C ^a   Rordorf, T ^b   Suter, S L ^c   Pfeiffer, D ^a   Wild, D ^a   Schroder S ^d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Medizinische Klinik Zurich   (Switzerland)

^c Stadtspital Triemli Departement fur Innere Medizin Abteilung fur Gastroenterologie   (Switzerland)

^d Institut für Pathologie   (Germany)

Author keywords

123I metaiodobenzylguanidine (MIBG); Adrenal cortical carcinoma; Adrenal gland; Histology; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; METAIODOBENZYLGUANIDINE I 123; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOISOTOPE;

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; CASE REPORT; CHROMAFFIN CELL; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; FALSE POSITIVE RESULT; HUMAN; ISOTOPE LABELING; ADRENAL CORTEX TUMOR; ADRENAL TUMOR; DIFFERENTIAL DIAGNOSIS; METASTASIS; PATHOLOGY; PHEOCHROMOCYTOMA; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IODINE RADIOISOTOPES; NEOPLASM METASTASIS; PHEOCHROMOCYTOMA; RADIOISOTOPES;

EID: 34447267185     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-006-0832-3     Document Type: Article

References (22)

1. Alsabeh R, Mazoujian G, Goates J et al. (1995) Adrenal cortical tumors clinically mimicking pheochromocytoma. Am J Clin Pathol 104: 392-390
2. 123I metaiodobenzylguanidine. Clin Nucl Med 19: 221-223
3. Burak N, Loesch J, Costa J (1959) Adrenocortical adenoma, clinically simulating pheochromocytoma. New York J Med 59: 18-51
4. El-Naggar AK, Evans DB, Mackay B (1991) Oncocytic adrenal cortical carcinoma. Ultrastruct Pathol 15: 549-556
5. Hoang MP, Ayala AG, Albores-Saavedra J (2002) Oncocytic adrenocortical carcinoma: a morphologic, immunohistochemical and ultrastructural study of four cases. Mod Pathol 15: 973-978
6. Horne T, Glaser B, Krausz Y et al. (1991) Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue. Clin Nucl Med 16: 239-242
7. Houghton A (1990) False-positive diagnosis of adrenal phaeochromocytoma on metaiodobenzylguanidine (MIBG) scan. Br J Clin Pract 44: 411-412
8. 123I-MIBG images in focal pyelonephritis. Clin Nucl Med 15: 821-824
9. Kekäläinen P, Alhava E, Vanninen E, Niskanen L (2003) A pitfall of metaiodobenzylguanidine scan: paraganglioma in close proximity to adrenocortical adenoma. Exp Clin Endocrinol Diabetes 111: 294-297
10. Komminoth P, Roth J, Schröder S et al. (1995) Overlapping expression of immunohistochemical markers and synaptophysin mRNA in phaeochromocytomas and adrenal carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Lab Invest 72: 424-431
11. Krubsack AJ, Arnout MA, Hagen TC et al. (1988) Zona fasciculata cortical adenoma and adrenal medullary hyperplasia in MEN 2 patient: unique concurrent presentation.Clin Nucl Med 13: 730-733
12. Letizia C, De Toma G, Massa R et al. (1998) False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan. J Endocrinol Invest 21: 779-783
13. 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumors. Nucl Med Commun 23: 951-960
14. Miettinen M (1992) Neuroendocrine differentiation in adrenal cortical carcinoma. New immunhistochemical findings supported by electron microscopy. Lab Invest 66: 169-174
15. Ong YY, Cohn D, Wijaya J, Roach P (2002) The importance of renal localization with MIBG scintigraphy. Clin Nucl Med 27: 479-482
16. Rainis T, Ben-Haim S, Dickstein G (2000) False positive metaiodobenzyguanidine scan in a patient with huge adrenocortical carcinoma. J Clin Endocrinol Metab 85: 5-7
17. Schröder S, Niendorf A, Achilles E et al. (1990) Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11. Vichows Arch [A] 417: 89-96
18. Schröder S, Padberg BC, Achilles E et al. (1992) Immunocytochemistry in adrenocortical tumours: a clinicomorphologic study of 72 neoplasms. Virchows Arch [A] 420: 65-70
19. Shapiro B, Copp J, Sisson J et al. (1985) Iodine-131 metaiodobenzylguanidine for locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26: 576-585
20. Simon S, Tötsch M, Schmidlin F et al. (2003) Adrenal cortical phaeochromocytoma: a case report of a rare entity. Exp Clin Endocrinol Diabetes 111: 111-114
21. Sone H, Okuda Y, Nakamura Y et al. (1996) Radioiodinated metaiodobenzylguanidine scintigraphy for phaeochromocytoma. Horm Res 46: 138-142
22. 131I] iodobenzylguanididine in the scintigraphic evaluation of neural crest tumors. Q J Nucl Med 39: 13-16